trial

Repetitive Transcranial Magnetic Stimulation

NCTId NCT00169689
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 40 (actual)
Sponsored by Heinrich-Heine University, Duesseldorf
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
40 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2003-06
Primary completion
—
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
rTMS, "repetitive transcranial magnetic stimulation"rTMS

Sponsors

Heinrich-Heine University, DuesseldorfLead Sponsor

Investigators

3
Joachim Cordes, MDPrincipal Investigator
PD Dr. W WölwerPrincipal Investigator
PD Dr. MW AgelinkPrincipal Investigator

Sites

1 total
Düsseldorf, Germany

Facts & assertions

3 sourced
Enrollment
40
Phase
NA
Status
COMPLETED
relationships
The graph out of here
drug
rTMS, "repetitive transcranial magnetic stimulation"
drug
rTMS
drug
lead_sponsor
Heinrich-Heine University, Duesseldorf
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Joachim Cordes, MD
person
PD Dr. W Wölwer
person
PD Dr. MW Agelink
person